ResearchMoz

United States In Vitro Diagnostics Market Outlook to 2016

Publisher Name » GlobalData
Published Date » 2010-07-29
No. Of Pages » 261

GlobalDatas new report, US In Vitro Diagnostics Market Outlook to 2016 provides key market data on the US In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. 
  • 2009 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the US In Vitro Diagnostics (IVD) market.
  • Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the US In Vitro Diagnostics (IVD) competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contents

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12

2 Introduction 15
2.1 What is This Report About? 15

3 In Vitro Diagnostics In United States 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2009 19
3.4 In Vitro Diagnostics Market, United States, Category Contribution (%), 2009 20
3.5 In Vitro Diagnostics, United States, Company Share (2008-2009) 27

4 Clinical Chemistry In United States 29
4.1 Clinical Chemistry, Market Segmentation 29
4.2 Clinical Chemistry Market, United States, Revenue Mix ($m), 2009 30
4.3 Clinical Chemistry Market, United States, Category Contribution (%), 2009 31
4.4 Clinical Chemistry Overall Revenue (2002-2016) 32
4.5 Clinical Chemistry Distribution Share (2008-2009) 44
4.6 Clinical Chemistry, United States, Company Share (2008-2009) 45

5 Genetic Testing In United States 47
5.1 Genetic Testing, Market Segmentation 47
5.2 Genetic Testing Market, United States, Revenue Mix ($m), 2009 48
5.3 Genetic Testing Market, United States, Category Contribution (%), 2009 49
5.4 Genetic Testing Overall Revenue (2002-2016) 50
5.5 Genetic Testing Distribution Share (2008-2009) 54
5.6 Genetic Testing, United States, Company Share (2008-2009) 55

6 Haematology In United States 57
6.1 Haematology, Market Segmentation 57
6.2 Haematology Market, United States, Revenue Mix ($m), 2009 58
6.3 Haematology Market, United States, Category Contribution (%), 2009 59
6.4 Haematology Overall Revenue (2002-2016) 60
6.5 Haematology Distribution Share (2008-2009) 84
6.6 Haematology, United States, Company Share (2008-2009) 85

7 Histology And Cytology In United States 87
7.1 Histology and Cytology, Market Segmentation 87
7.2 Histology and Cytology Market, United States, Revenue Mix ($m), 2009 88
7.3 Histology and Cytology Market, United States, Category Contribution (%), 2009 89
7.4 Histology and Cytology Overall Revenue (2002-2016) 90
7.5 Histology and Cytology Distribution Share (2008-2009) 98
7.6 Histology and Cytology, United States, Company Share (2008-2009) 99

8 Immuno Chemistry In United States 101
8.1 Immuno Chemistry, Market Segmentation 101
8.2 Immuno Chemistry Market, United States, Revenue Mix ($m), 2009 102
8.3 Immuno Chemistry Market, United States, Category Contribution (%), 2009 103
8.4 Immuno Chemistry Overall Revenue (2002-2016) 104
8.5 Immuno Chemistry Distribution Share (2008-2009) 124
8.6 Immuno Chemistry, United States, Company Share (2008-2009) 125

9 Infectious Immunology In United States 127
9.1 Infectious Immunology, Market Segmentation 127
9.2 Infectious Immunology Market, United States, Revenue Mix ($m), 2009 128
9.3 Infectious Immunology Market, United States, Category Contribution (%), 2009 129
9.4 Infectious Immunology Overall Revenue (2002-2016) 130
9.5 Infectious Immunology Distribution Share (2008-2009) 134
9.6 Infectious Immunology, United States, Company Share (2008-2009) 135

10 Microbiology Culture In United States 137
10.1 Microbiology Culture, Market Segmentation 137
10.2 Microbiology Culture Market, United States, Revenue Mix ($m), 2009 138
10.3 Microbiology Culture Market, United States, Category Contribution (%), 2009 139
10.4 Microbiology Culture Overall Revenue (2002-2016) 140
10.5 Microbiology Culture Distribution Share (2008-2009) 148
10.6 Microbiology Culture, United States, Company Share (2008-2009) 149

11 Overview of Key Companies in United States In Vitro Diagnostics Market 150
11.1 Siemens Healthcare 150
11.2 Abbott Laboratories 151
11.3 F. Hoffmann-La Roche Ltd. 152
11.4 Beckman Coulter, Inc. 153
11.5 Becton, Dickinson and Company 154
11.6 Ortho-Clinical Diagnostics Inc. 155
11.7 Genzyme Corporation 156
11.8 Inverness Medical Innovations, Inc. 156
11.9 Baxter International Inc. 156
11.10 Thoratec Corporation 157
11.11 bioMerieux S.A. 157
11.12 Bio-Rad Laboratories, Inc. 157
11.13 Hologic, Inc. 158
11.14 OLYMPUS CORPORATION 158
11.15 Mindray Medical International Limited 159
11.16 Sysmex Corporation 159
11.17 Ventana Medical Systems, Inc. 159
11.18 DiaSorin S.p.A 160
11.19 Qiagen N.V. 160
11.20 Gen-Probe Incorporated 161
11.21 Phadia AB 161
11.22 Aethlon Medical, Inc. 161
11.23 Calypte Biomedical Corporation 162
11.24 Assay Designs, Inc. 162
11.25 BioTime, Inc. 162
11.26 Daxor Corporation 163
11.27 IRIS International, Inc. 163
11.28 Escalon Medical Corp. 164
11.29 Immucor, Inc. 164
11.30 Streck, Inc. 165
11.31 SurModics, Inc. 165
11.32 OraSure Technologies, Inc. 165
11.33 Meder International Group, Inc. 166
11.34 Micronics, Inc. 166
11.35 Instrumentation Laboratory 166
11.36 AdvanDx, Inc. 167
11.37 Biocare Medical LLC 167
11.38 Biocell Laboratories, Inc. 167
11.39 Protein Discovery, Inc. 168
11.40 Binax, Inc. 168
11.41 SYNTRON Bioresearch, Inc. 168
11.42 Bio/Data Corporation 168
11.43 Cartagen Molecular Systems, Inc. 169
11.44 Maxwell Sensors Inc. 169
11.45 Radient Pharmaceuticals Corporation 169
11.46 Milagen, Inc. 170
11.47 Lesanne Life Sciences, LLC 170
11.48 Exagen Diagnostics, Inc. 170
11.49 Celerus Diagnostics, Inc. 171
11.50 Biomedical Science Consulting Company, Inc. 171
11.51 BellBrook Labs 171
11.52 Monogen, Inc. 172
11.53 INOVA Diagnostics, Inc. 172
11.54 Haematologic Technologies, Inc. 172
11.55 EraGen Biosciences, Inc. 173

12 In Vitro Diagnostics Market Pipeline Products 174
12.1 Clinical Chemisty Market Pipeline Products 174
12.2 Immuno Chemistry Market Pipeline Products 176
12.3 Haematology Market Pipeline Products 177
12.4 Infectious Immunology Market Pipeline Products 178
12.5 Microbiology Culture Market Pipeline Products 180
12.6 Histology and Cytology Market Pipeline Products 181
12.7 Genetic Testing Market Pipeline Products 182

13 Financial Deals Landscape 184
13.1 Merger 184
13.2 Acquisition 186

14 Recent Developments 203
14.1 Strategy and Business Planning 203
14.2 Legal and Regulatory 215
14.3 Government and Public Interest 219
14.4 Product News 227

15 Appendix 246
15.1 Definitions of Markets Covered in the Report 247
15.2 Research Methodology 254
15.3 Secondary Research 255
15.4 Primary Research 255
15.5 Models 256
15.6 Forecasts 256
15.7 Expert Panels 256
15.8 GlobalData Consulting 256
15.9 Currency Conversion 257
15.10 Contact Us 257
15.11 Disclaimer 257

List of Tables

 
Table 1: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 4
Table 2: In Vitro Diagnostics Market, United States, Category Contribution (%), 2009 4
Table 3: In Vitro Diagnostics, United States, Cross-Category Analysis, 2002-2016 4
Table 4: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009 4
Table 5: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016 4
Table 6: In Vitro Diagnostics, United States, Company Share by Revenue ($m), 2008-2009 4
Table 7: Clinical Chemistry Market, United States, Category Contribution (%), 2009 4
Table 8: Clinical Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 9: Clinical Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 10: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 11: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 12: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 13: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 14: Clinical Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 15: Clinical Chemistry, United States, Company Share by Revenue ($m), 2008-2009 4
Table 16: Genetic Testing Market, United States, Category Contribution (%), 2009 4
Table 17: Genetic Testing, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 18: Genetic Testing, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 19: Genetic Testing, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 20: Genetic Testing, United States, Company Share by Revenue ($m), 2008-2009 4
Table 21: Haematology Market, United States, Category Contribution (%), 2009 4
Table 22: Haematology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 23: Haematology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 24: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 25: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 26: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 27: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 28: Haemostasis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 29: Haemostasis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 30: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 31: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 32: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 33: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 34: Haematology, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 35: Haematology, United States, Company Share by Revenue ($m), 2008-2009 4
Table 36: Histology and Cytology Market, United States, Category Contribution (%), 2009 4
Table 37: Histology And Cytology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 38: Histology And Cytology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 39: Histology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 40: Histology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 41: Histology And Cytology, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 42: Histology And Cytology, United States, Company Share by Revenue ($m), 2008-2009 4
Table 43: Immuno Chemistry Market, United States, Category Contribution (%), 2009 4
Table 44: Immuno Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 45: Immuno Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 46: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 47: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 48: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 49: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 50: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 51: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 52: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 53: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 54: Immuno Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 55: Immuno Chemistry, United States, Company Share by Revenue ($m), 2008-2009 4
Table 56: Infectious Immunology Market, United States, Category Contribution (%), 2009 4
Table 57: Infectious Immunology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 58: Infectious Immunology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 59: Infectious Immunology, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 60: Infectious Immunology, United States, Company Share by Revenue ($m), 2008-2009 4
Table 61: Microbiology Culture Market, United States, Category Contribution (%), 2009 4
Table 62: Microbiology Culture, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Table 63: Microbiology Culture, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Table 64: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Table 65: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Table 66: Microbiology Culture, United States, Distribution Share by Revenue ($m), 2008-2009 4
Table 67: Microbiology Culture, United States, Company Share by Revenue ($m), 2008-2009 4
Table 68: Clinical Chemisty Market Pipeline Products 4
Table 69: Immuno Chemistry Market Pipeline Products 4
Table 70: Haematology Market Pipeline Products 4
Table 71: Infectious Immunology Market Pipeline Products 4
Table 72: Microbiology Culture Market Pipeline Products 4
Table 73: Histology and Cytology Market Pipeline Products 4
Table 74: Genetic Testing Market Pipeline Products 4
Table 75: Macada Holding To Merge With Undisclosed Company 4
Table 76: Carilion Clinic To Merge With Spectrum Laboratory Network 4
Table 77: Thermo Fisher Scientific Completes Acquisition Of Ahura Scientific 4
Table 78: PerkinElmer To Acquire Remaining Stake In AB SCIEX From Danaher 4
Table 79: Millipore Receives 79% Of Shareholders Approval For Its Acquisition By Merck 4
Table 80: Quidel Completes Acquisition Of Diagnostic HYBRIDS 4
Table 81: Inverness Medical Innovations To Acquire Kroll Laboratory Specialists From Kroll 4
Table 82: Medco Health Solutions Completes Acquisition Of DNA Direct 4
Table 83: Danaher Acquires Remaining 50% Interest In AB SCIEX From Life Technologies 4
Table 84: MDS Completes Sale Of MDS Analytical Technologies To Danaher 4
Table 85: QuantRx Biomedical To Acquire NuRx Pharmaceuticals 4
Table 86: Predictive Biosciences Acquires OncoDiagnostic Laboratory 4
Table 87: Bio-Rad Laboratories Completes Acquisition Of Medical Diagnostics Segment From Biotest 4
Table 88: USD to Local Currency, United States, Average Actual Rate 2002-2009 4

List of Figures

 
Figure 1: In Vitro Diagnostics, Market Segmentation 4
Figure 2: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016 4
Figure 3: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2009 4
Figure 4: In Vitro Diagnostics Market, United States, Category Contribution (%), 2009 4
Figure 5: In Vitro Diagnostics, United States, Cross-Category Analysis, 2002-2016 4
Figure 6: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009 4
Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016 4
Figure 8: In Vitro Diagnostics, United States, Company Share (%), 2009 4
Figure 9: Clinical Chemistry, Market Segmentation 4
Figure 10: Clinical Chemistry Market, United States, Revenue Mix ($m), 2009 4
Figure 11: Clinical Chemistry Market, United States, Category Contribution (%), 2009 4
Figure 12: Clinical Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 13: Clinical Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 14: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 15: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 16: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 17: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 18: Clinical Chemistry, United States, Company Share (%), 2009 4
Figure 19: Genetic Testing, Market Segmentation 4
Figure 20: Genetic Testing Market, United States, Revenue Mix ($m), 2009 4
Figure 21: Genetic Testing Market, United States, Category Contribution (%), 2009 4
Figure 22: Genetic Testing, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 23: Genetic Testing, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 24: Genetic Testing, United States, Company Share (%), 2009 4
Figure 25: Haematology, Market Segmentation 4
Figure 26: Haematology Market, United States, Revenue Mix ($m), 2009 4
Figure 27: Haematology Market, United States, Category Contribution (%), 2009 4
Figure 28: Haematology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 29: Haematology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 30: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 31: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 32: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 33: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 34: Haemostasis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 35: Haemostasis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 36: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 37: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 38: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 39: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 40: Haematology, United States, Company Share (%), 2009 4
Figure 41: Histology and Cytology, Market Segmentation 4
Figure 42: Histology and Cytology Market, United States, Revenue Mix ($m), 2009 4
Figure 43: Histology and Cytology Market, United States, Category Contribution (%), 2009 4
Figure 44: Histology And Cytology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 45: Histology And Cytology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 46: Histology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 47: Histology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 48: Histology And Cytology, United States, Company Share (%), 2009 4
Figure 49: Immuno Chemistry, Market Segmentation 4
Figure 50: Immuno Chemistry Market, United States, Revenue Mix ($m), 2009 4
Figure 51: Immuno Chemistry Market, United States, Category Contribution (%), 2009 4
Figure 52: Immuno Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 53: Immuno Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 54: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 55: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 56: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 57: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 58: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 59: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 60: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 61: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 62: Immuno Chemistry, United States, Company Share (%), 2009 4
Figure 63: Infectious Immunology, Market Segmentation 4
Figure 64: Infectious Immunology Market, United States, Revenue Mix ($m), 2009 4
Figure 65: Infectious Immunology Market, United States, Category Contribution (%), 2009 4
Figure 66: Infectious Immunology, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 67: Infectious Immunology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 68: Infectious Immunology, United States, Company Share (%), 2009 4
Figure 69: Microbiology Culture, Market Segmentation 4
Figure 70: Microbiology Culture Market, United States, Revenue Mix ($m), 2009 4
Figure 71: Microbiology Culture Market, United States, Category Contribution (%), 2009 4
Figure 72: Microbiology Culture, United States, Revenue ($m) by Segment, Historic, 2002-2009 4
Figure 73: Microbiology Culture, United States, Revenue ($m) by Segment, Forecast, 2009-2016 4
Figure 74: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 4
Figure 75: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 4
Figure 76: Microbiology Culture, United States, Company Share (%), 2009 4
Figure 77: Siemens Healthcare, Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 78: Abbott Laboratories, Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 79: F. Hoffmann-La Roche Ltd., Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 80: Beckman Coulter, Inc., Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 81: Becton, Dickinson and Company, Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),United States In Vitro Diagnostics Market, 2009 4
Figure 83: GlobalData Methodology 4

Upcoming Reports:

RFID Equipment Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Advancements in RFID technology has resulted in enhanced capabilities and reduction in cost of this technology are some of the major factors driving this market as well as its applications in various sectors. RFID applications offer innovation in the form of tracking on a real-time basis, which can be used in various industries such as, Aerospace/Defense, Healthcare, Transport/Automotive, Retail and Others. Chip less RFID has given a new dimension to the track and trace market due to which global market for RFID tags and Readers is expected to grow at a CAGR of 16% over the...
Carrier Ethernet Equipment Market - Global Industry size, market share, trends, analysis and forecasts 2012 - 2018
By - Transparency Market Research
Carrier Ethernet equipment market is expected to grow at the compounded annual growth rate of 19.2 percent up to 2014. One of the key factors driving this market growth is the increasing adoption of IP based next generation networks. The US market for Carrier Ethernet equipments is also witnessing stupendous growth rate due to the increasing adoption of carrier Ethernet for mobile backhaul. However, rapid advancements in technology are posing major challenge to the growth of this market as it is encouraging end users to delay equipment purchase.  Increasing use of mobile...
Nanocoatings Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Properties like anti-corrosion, flame retardant, UV stability, gloss retention, etc. are enhanced significantly with the use of nanostructured materials. Nanocoatings are majorly used in construction for exterior protection, military and defense for anti-corrosion coatings of military vehicles, household cleansing, and automotives. Defense Industry is one of the biggest markets for Nanocoatings technology where anti-corrosive coatings are increasingly applied. These coatings are driving revenues in the oil and gas industry for protective surfaces in pipelines and harsh...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...